Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Ending Cash Position : ¥237 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co Ending Cash Position?

Hainan Huluwa Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥237 Mil.

Hainan Huluwa Pharmaceutical Group Co's quarterly Ending Cash Position increased from Sep. 2023 (¥178 Mil) to Dec. 2023 (¥521 Mil) but then declined from Dec. 2023 (¥521 Mil) to Mar. 2024 (¥237 Mil).

Hainan Huluwa Pharmaceutical Group Co's annual Ending Cash Position declined from Dec. 2021 (¥473 Mil) to Dec. 2022 (¥464 Mil) but then increased from Dec. 2022 (¥464 Mil) to Dec. 2023 (¥521 Mil).

Hainan Huluwa Pharmaceutical Group Co Ending Cash Position Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co Ending Cash Position Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

154.09

340.88

472.58

463.84

520.94

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															322.61	217.10	177.90	520.94	236.87

Hainan Huluwa Pharmaceutical Group Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hainan Huluwa Pharmaceutical Group Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	463.842	+	57.096
	=	521

Hainan Huluwa Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	520.938	+	-284.07
	=	237

Hainan Huluwa Pharmaceutical Group Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hainan Huluwa Pharmaceutical Group Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300

Website

http://www.huluwayaoye.com

Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines